Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Overgaard

Showing results (51-60 of 389) with videos related to

Pageof 39
Sort By:
Seminars in Radiation Oncology|March 4, 2008
Genetic markers for prediction of normal tissue toxicity after radiotherapyJan Alsner, Christian Nicolaj Andreassen, Jens Overgaard
Acta Oncologica (Stockholm, Sweden)|July 29, 2008
Resolution in PET hypoxia imaging: voxel size mattersMorten Busk, Michael R Horsman, Jens Overgaard
Genes, Chromosomes & Cancer|June 4, 2008
A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomasEmilia Wiechec, Jens Overgaard, Lise Lotte Hansen
Acta Oncologica (Stockholm, Sweden)|April 26, 2005
The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinomaJesper Grau Eriksen, Torben Steiniche, Jens Overgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2013
Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trialsPernille Lassen, Jens Overgaard, Jesper Grau Eriksen
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 8, 2013
Independent prospective validation of a predictive test for risk of radiation induced fibrosis based on the gene expression pattern in fibroblasts irradiated in vitroChristian Nicolaj Andreassen, Jens Overgaard, Jan Alsner
Scandinavian Journal of Urology and Nephrology|June 19, 2004
Early and late treatment-related morbidity following radical cystectomyMarianne M Knap, Finn Lundbeck, Jens Overgaard
Acta Oncologica (Stockholm, Sweden)|February 21, 2013
In response to the commentary 'Particle species dependence of cell survival relative biological effectiveness: Evident and not negligible' by Thomas Friedrich, Marco Durante & Michael ScholzBrita Singers Sørensen, Jens Overgaard, Niels Bassler
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 20, 2007
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trialsMarie Overgaard, Hanne M Nielsen, Jens Overgaard
The Lancet. Oncology|April 3, 2010
Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?Jesper Grau Eriksen, Pernille Lassen, Jens Overgaard
Pageof 39

Showing results (51-60 of 389) with videos related to

Sort By:
Pageof 39
Seminars in Radiation Oncology|March 4, 2008
Genetic markers for prediction of normal tissue toxicity after radiotherapyJan Alsner, Christian Nicolaj Andreassen, Jens Overgaard
Acta Oncologica (Stockholm, Sweden)|July 29, 2008
Resolution in PET hypoxia imaging: voxel size mattersMorten Busk, Michael R Horsman, Jens Overgaard
Genes, Chromosomes & Cancer|June 4, 2008
A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomasEmilia Wiechec, Jens Overgaard, Lise Lotte Hansen
Acta Oncologica (Stockholm, Sweden)|April 26, 2005
The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinomaJesper Grau Eriksen, Torben Steiniche, Jens Overgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2013
Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trialsPernille Lassen, Jens Overgaard, Jesper Grau Eriksen
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 8, 2013
Independent prospective validation of a predictive test for risk of radiation induced fibrosis based on the gene expression pattern in fibroblasts irradiated in vitroChristian Nicolaj Andreassen, Jens Overgaard, Jan Alsner
Scandinavian Journal of Urology and Nephrology|June 19, 2004
Early and late treatment-related morbidity following radical cystectomyMarianne M Knap, Finn Lundbeck, Jens Overgaard
Acta Oncologica (Stockholm, Sweden)|February 21, 2013
In response to the commentary 'Particle species dependence of cell survival relative biological effectiveness: Evident and not negligible' by Thomas Friedrich, Marco Durante & Michael ScholzBrita Singers Sørensen, Jens Overgaard, Niels Bassler
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 20, 2007
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trialsMarie Overgaard, Hanne M Nielsen, Jens Overgaard
The Lancet. Oncology|April 3, 2010
Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?Jesper Grau Eriksen, Pernille Lassen, Jens Overgaard
Pageof 39